The field of Hepatitis C Virus (HCV) treatment is changing at an extremely rapid pace with the advent of highly effective directly-acting agents (DAAs); the challenges of treating co-infected patients are significant.
Although the primary mission of any AETC is focused on HIV/AIDS, viral hepatitis is increasingly important both independent of and related to HIV. In the U S, approximately 730,000 people are chronically infected with hepatitis B virus (HBV), while over 2.7 million people are chronically infected with hepatitis C virus (HCV).
To augment provider education in this arena, we actively incorporated viral hepatitis education into both live and web-based programming for HIV providers, trainees, and other healthcare providers. Cody Chastain, MD, a speaker for the TN AETC, Vanderbilt University, and the Tennessee Department of Health (TDH) presents on this topic weekly and has championed HCV education for providers across the state.
Cody Chastain, MD
Assistant Professor
Viral Hepatitis Program
Division of Infectious Diseases
Department of Medicine
Vanderbilt University Medical Center
cody.a.chastain@vanderbilt.edu